1. Home
  2. VRAX vs SILO Comparison

VRAX vs SILO Comparison

Compare VRAX & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • SILO
  • Stock Information
  • Founded
  • VRAX 2013
  • SILO 2010
  • Country
  • VRAX United Kingdom
  • SILO United States
  • Employees
  • VRAX N/A
  • SILO N/A
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • SILO Apparel
  • Sector
  • VRAX Health Care
  • SILO Consumer Discretionary
  • Exchange
  • VRAX Nasdaq
  • SILO Nasdaq
  • Market Cap
  • VRAX 7.3M
  • SILO 8.8M
  • IPO Year
  • VRAX 2022
  • SILO N/A
  • Fundamental
  • Price
  • VRAX $1.90
  • SILO $1.42
  • Analyst Decision
  • VRAX
  • SILO
  • Analyst Count
  • VRAX 0
  • SILO 0
  • Target Price
  • VRAX N/A
  • SILO N/A
  • AVG Volume (30 Days)
  • VRAX 282.7K
  • SILO 309.4K
  • Earning Date
  • VRAX 02-05-2025
  • SILO 02-25-2025
  • Dividend Yield
  • VRAX N/A
  • SILO N/A
  • EPS Growth
  • VRAX N/A
  • SILO N/A
  • EPS
  • VRAX N/A
  • SILO N/A
  • Revenue
  • VRAX $84,872.00
  • SILO $72,102.00
  • Revenue This Year
  • VRAX $5,169.18
  • SILO $1.86
  • Revenue Next Year
  • VRAX $66.97
  • SILO N/A
  • P/E Ratio
  • VRAX N/A
  • SILO N/A
  • Revenue Growth
  • VRAX 7.03
  • SILO N/A
  • 52 Week Low
  • VRAX $0.60
  • SILO $0.77
  • 52 Week High
  • VRAX $9.00
  • SILO $4.50
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 49.13
  • SILO 42.07
  • Support Level
  • VRAX $1.58
  • SILO $1.42
  • Resistance Level
  • VRAX $2.10
  • SILO $1.57
  • Average True Range (ATR)
  • VRAX 0.25
  • SILO 0.17
  • MACD
  • VRAX 0.01
  • SILO -0.07
  • Stochastic Oscillator
  • VRAX 47.88
  • SILO 2.82

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Share on Social Networks: